Videos

Edward Garon, MD, MS, provides an overview on the basics of immunotherapy for NSCLC and SCLC, a topic he presented at the virtual 2022 GDU Lung Cancers meeting.

Matthew Goetz, MD, discusses a second interim analysis on OS results for the MONARCH 3 trial, demonstrating prolonged OS with the addition of abemaciclib to a nonsteroidal aromatase inhibitor in patients with HR-positive, HER2-negative...

Benjamin Levy, MD, reviews his talk on targeted therapies for patients with MET-dependent lung cancers, presented at the virtual 2022 GDU Lung Cancers meeting.

Bernd Kasper, MD, PhD, discusses findings from the phase 3 DeFi trial, in which nirogacestat demonstrated a 71% reduction in the risk of disease progression or death vs placebo in patients with progressing desmoid tumors.

Sara Tolaney, MD, discusses results from AMEERA-3, an open-label randomized phase 2 trial that explored amcenestrant vs physician’s choice of endocrine therapy in patients with endocrine-resistant ER-positive, HER2-negative advanced breast...

Denis Soulières, MD, discusses long-term follow-up data from the phase 3 KEYNOTE-040 and KEYNOTE-048 clinical trials examining pembrolizumab for patients with head and neck squamous cell carcinoma.

Joseph Renzulli, MD, discusses findings from the phase 2 ENACT trial, evaluating enzalutamide monotherapy vs active surveillance in patients with low- or intermediate-risk localized prostate cancer.

Erika Hamilton, MD, shares insights about the recent FDA approval of trastuzumab deruxtecan for patients with HER2-low metastatic breast cancer and the data that led to this approval.

David Ilson, MD, PhD, discusses the role of radiotherapy in treating gastroesophageal junction cancer, which he presented at the Great Debates & Updates in Gastrointestinal Malignancies meeting.

Rachna Shroff, MD, highlights recent developments in the treatment of cholangiocarcinoma, including updates in novel and targeted therapies, during her presentation at the Great Debates and Updates in Gastrointestinal Malignancies meeting.